Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impaired neurotransmitter release in Alzheimer's and Parkinson's diseases.

Neuro-degenerative diseases - 1 Jan 2010

Shen Jie

Abstract excerpt

Mutations in several causative genes have been linked to monogenic forms of Alzheimer's disease (AD) or Parkinson's disease (PD). To look for possible common pathogenic mechanisms underlying age-related neurodegeneration in AD and PD, we employed genetic approaches to investigate systematically the roles of these gene products (e.g. presenilins (PS) for AD; Parkin, DJ-1, PINK1 and LRRK2 for PD) in the mouse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to PINK1 gene
Share to Membrane Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Nerve Tissue Proteins

Share to Neurotransmitter Agents

Share to Parkinson Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 20173332
DOI: 10.1159/000285511
PMCID: PMC2859234

Genes

PINK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impaired neurotransmitter release in Alzheimer's and Parkinson's diseases.PMID 20173332Read ↗

Human neurons lacking amyloid precursor protein exhibit cholesterol-associated developmental and presynaptic deficitsSemantic proximity Read ↗

Hippocampal synaptic plasticity in Alzheimer’s disease: what have we learned so far from transgenic models?Semantic proximity Read ↗

Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.Semantic proximity Read ↗

Parkin overexpression ameliorates hippocampal long-term potentiation and -amyloid load in an Alzheimer's disease mouse modelSemantic proximity Read ↗

The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus.Semantic proximity Read ↗

Intracellular Ca 2+ stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer’s diseaseSemantic proximity Read ↗

Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer's Disease.Semantic proximity Read ↗

Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer's disease-relevant brain circuits.Semantic proximity Read ↗

Function and Dysfunction of PresenilinSemantic proximity Read ↗

The role of APP and APLP for synaptic transmission, plasticity, and network function: lessons from genetic mouse modelsSemantic proximity Read ↗

Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s diseaseSemantic proximity Read ↗

Age-dependent concomitant changes in synaptic dysfunction and GABAergic pathway in the APP/PS1 mouse model.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.